Plenary Session
The Crown Jewels Of Scientific Abstracts
Among the 626 scientific oral and poster abstracts accepted for presentation in Anaheim, six “gems” were selected for the plenary session. Be sure to make time in your Annual Meeting schedule to hear these outstanding presentations, Monday from 8:30 to 10:00 am in Room 204B.
- The Canadian Transfusion Error Surveillance System (TESS): Results from the First Two Years of a National Pilot Project, Jeannie L. Callum, MD, presenting. This study analyzed data from 11 hospitals in four provinces to determine rates for several errors, including ABO-incompatible transfusions, inappropriate transfusions, product wastage, the need for sample re-collection and treatment delays. Data were stratified for hospital size, personnel involved and points in the “transfusion chain” where errors occurred.
- U.S. Blood Donor Screening for Trypanosoma cruzi: Clinical Studies and Early Assessment of Prevalence, Susan L. Stramer, PhD, presenting. In support of test licensure, a prevalence study was initiated under an investigational new drug protocol. The study involved areas where T. cruzi-infected donors had already been identified. Donors with reactive and nonreactive gray zone test results were asked to participate in follow-up studies that included additional laboratory assays as well as a donor risk survey.
- Evaluation of Proposed FDA Criteria for Radiolabeled Red Cell Recovery Trials, Larry J. Dumont, MBA, PhD, presenting for the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. The objective of this study was to define the ability of systems for red cell collection and storage to meet the criteria set by the FDA for recovery of autologous red cells 24 hours after reinfusion. Those criteria call for a mean recovery of 75%, a standard deviation of 9%, and a greater than 75% rate of success for individual recovery.
- Relationship of HLA Antibodies in Blood Donors to Pregnancy and Transfusion History, Darrell J. Triulzi, MD, presenting. For this study, six blood centers recruited approximately 7,900 blood donors and asked for a detailed history of pregnancy and/or transfusion, as well as a blood sample for leukocyte antibody testing. The aim was to determine the percentage of donors whose plasma-rich components would be diverted in an effort to reduce the risk of transfusion-related acute lung injury.
- Ex-Vivo Production of Human Red Blood Cells by Coculture with Human Mesenchymal Stem Cells, Eun-Jung Baek, MD, PhD, presenting. This study compared the differentiation of CD34+ cells into erythroid lineage and massive production of red cells by coculture with either marrow-derived or cord blood mesenchymal stem cells. The protocols involved supplementation with stem cell factor, interleukin 3, erythropoietin, thrombopoietin, Flt-3 ligand, or absence of any cytokines.
- Complications of Whole Blood Donation in 16- and 17-Year-Old Allogeneic Donors, Anne F. Eder, MD, PhD, presenting. The goal of this study was to evaluate the safety of allowing 16-year-old high school students to donate blood with parental consent. Complications analyzed included prefaint reactions, loss of consciousness (with and without injury), hematoma, prolonged recovery, and receipt of outside medical care.
Abstracts at a Glance
Category 2007 2006 2005 2004 2003 2002 2001
Submitted
Domestic 570 545 521 533 457 465 405
International 307 250 281 226 230 172 246
Total 877 795 802 759 687 637 651
Accepted
Domestic 536 506 472 458 400 386 404
International 278 217 242 192 184 130 247
Total 814 723 714 650 584 516 531
Acceptance Rate (%)
Domestic 94 93 91 86 88 83 99
International 90 87 86 85 85 76 99
Scientific
Oral 114 105 102 108 142 100 150
Poster 512 398 424 382 302 309 294
Total 626 503 526 490 444 409 444
Administrative
Oral 24 24 24 12 8 9 6
Poster 158 189 158 152 132 90 74
Total 182 213 182 164 140 99 80
Note: Totals of scientific and administrative abstracts do not equal total
accepted because some presenters withdraw after acceptance.
Back to Saturday